Sawai Group Holdings Co., Ltd.

Equities

4887

JP3323040000

Pharmaceuticals

Market Closed - Japan Exchange 02:00:00 2024-04-26 am EDT 5-day change 1st Jan Change
5,957 JPY +0.17% Intraday chart for Sawai Group Holdings Co., Ltd. +0.39% +14.36%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Sawai Group Finalizes Sale of US Subsidiary MT
Bora Pharmaceuticals Co., LTD. completed the acquisition of Sawai America Holdings Inc. from Sawai Group Holdings Co., Ltd.. CI
Jefferies Adjusts Sawai Group’s Price Target to 5,000 Yen From 5,200 Yen, Keeps at Hold MT
Sawai Group Holdings Co., Ltd. Provides Year End Dividend Guidance for the Year Ending March 31, 2024 CI
Sawai Group Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024 CI
Bora Pharmaceuticals Co., LTD. agreed to acquire Sawai America Holdings Inc. from Sawai Group Holdings Co., Ltd. for approximately $210 million. CI
Neurolief Ltd. announced that it has received funding from Sawai Group Holdings Co., Ltd. CI
Jefferies Adjusts Sawai’s Price Target to 4,500 Yen From 3,500 Yen, Keeps at Hold MT
Sawai Group Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024 CI
Sawai Group Holdings Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Sawai Group Holdings Co., Ltd. Provides Dividend Guidance for the Second Quarter and Full Year Ending March 31, 2024 CI
Sawai Group Holdings Co., Ltd. Provides Consolidated Earnings Guidance for Period Ending September 2023 and Year Ending March 2024 CI
Sawai Group Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the First Half Year Ending September 2023 and Fiscal Year Ending March 31, 2024 CI
Sawai Group Holdings Co., Ltd. Announces Dividend for the Year Ended March 31, 2023, Payable on June 28, 2023; Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal Year Ending March 31, 2024 CI
Sawai Group Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Sawai Group Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2023 CI
Sawai Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023 CI
Sawai Group Holdings Co., Ltd. Announces Dividend for the Second Quarter Ending September 30, 2022, Payable on December 2, 2022; Provides Dividend Guidance for the Year Ending March 31, 2023 CI
Sawai Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023 CI
Sawai Group Holdings Co., Ltd. Provides Dividend Guidance for the Second Quarter and Full Year Ending March 31, 2023 CI
Sawai Group Holdings Co., Ltd. Provides Earnings Guidance for Period Ending September 2022 and Year Ending March 2023 CI
Japan Index Trades Steadily in Red; Round One Shares Gain 9% as May Sales Exceed Pre-Pandemic Level MT
Chugai Appeals Tokyo Court's Dismissal of Patent Infringement Lawsuit Against Sawai, Nichi-iko Pharmaceutical MT
Court Denies Chugai's Claim in Lawsuit Against Sawai, Nichi-iko MT
Transcript : Sawai Group Holdings Co., Ltd., 2022 Earnings Call, May 12, 2022
Chart Sawai Group Holdings Co., Ltd.
More charts
Sawai Group Holdings Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of medical and over-the-counter drugs. The Company operates in two segments. The Japan segment is engaged in medical and healthcare-related businesses such as manufacture and sale of pharmaceuticals and medical devices, as well as various related businesses. The America segment is engaged in the sale of manufactured pharmaceutical products to wholesale stores in America. The company is also engaged in the research and development of pharmaceutical products.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
5,957 JPY
Average target price
6,780 JPY
Spread / Average Target
+13.82%
Consensus
  1. Stock Market
  2. Equities
  3. 4887 Stock
  4. News Sawai Group Holdings Co., Ltd.
  5. Jefferies Adjusts Sawai’s Price Target to 4,500 Yen From 3,500 Yen, Keeps at Hold